AcelRx Pharmaceuticals Inc. (ACRX) is priced at $2.18 after the most recent trading session. At the very opening of the session, the stock price was $1.35 and reached a high price of $2.21, prior to closing the session it reached the value of $1.36. The stock touched a low price of $1.345.
Recently in News on December 10, 2020, AcelRx Pharmaceuticals Announces Publication of Clinical Data on Decreased Postoperative Opioid Requirements and Enhanced Postanesthesia Recovery Following Perioperative Use of DSUVIA®. AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the publication by the Journal of Universal Surgery of clinical data on the use of DSUVIA for acute perioperative pain management. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
AcelRx Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.21 on 01/12/21, with the lowest value was $1.21 for the same time period, recorded on 01/04/21.
AcelRx Pharmaceuticals Inc. (ACRX) full year performance was 14.44%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, AcelRx Pharmaceuticals Inc. shares are logging 2.35% during the 52-week period from high price, and 210.81% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.70 and $2.13.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 37545277 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the AcelRx Pharmaceuticals Inc. (ACRX) recorded performance in the market was 75.81%, having the revenues showcasing 10.10% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 218.65M, as it employees total of 25 workers.
The Analysts eye on AcelRx Pharmaceuticals Inc. (ACRX)
During the last month, 0 analysts gave the AcelRx Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.47, with a change in the price was noted +0.76. In a similar fashion, AcelRx Pharmaceuticals Inc. posted a movement of +53.52% for the period of last 100 days, recording 1,941,334 in trading volumes.
Technical rundown of AcelRx Pharmaceuticals Inc. (ACRX)
Raw Stochastic average of AcelRx Pharmaceuticals Inc. in the period of last 50 days is set at 97.16%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 97.16%. In the last 20 days, the company’s Stochastic %K was 76.86% and its Stochastic %D was recorded 69.74%.
Considering, the past performance of AcelRx Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 75.81%. Additionally, trading for the stock in the period of the last six months notably improved by 107.62%, alongside a boost of 14.44% for the period of the last 12 months. The shares increased approximately by 59.12% in the 7-day charts and went up by 53.52% in the period of the last 30 days. Common stock shares were driven by 10.10% during last recorded quarter.